
Welltower (WELL) Stock Forecast & Price Target
Welltower (WELL) Analyst Ratings
Bulls say
Welltower's diversified healthcare portfolio includes 2,391 in-place properties across various sectors, with over 100 properties in Canada and the United Kingdom, positioning the company well for further investment in mature healthcare systems. The company has demonstrated substantial financial growth, with projected FY24 revenue and EBITDA increases of 30% year-over-year and 22% year-over-year, respectively, driven by strong performance in Canadian operations and organic growth initiatives. Furthermore, Welltower's improved ESG ratings, moving from the bottom 10th percentile to the top 70th percentile, reflect a positive shift in corporate sustainability, which may enhance investor confidence and long-term value.
Bears say
Welltower's fundamental challenges include the difficulty of successfully integrating recent acquisitions, which, if not addressed, could lead to diminished EBITDA margins amid escalating competition in higher-growth segments. The company reported a disappointing EBITDA loss of $3.7 million, significantly falling short of both consensus estimates and guidance expectations, ultimately resulting in a revenue reduction of $56.6 million for 2024. Furthermore, the EBITDA guidance for 2024, excluding deferred revenue, was lower than anticipated by market analysts, indicating persistent operational and financial concerns that could adversely affect future performance.
This aggregate rating is based on analysts' research of Welltower and is not a guaranteed prediction by Public.com or investment advice.
Welltower (WELL) Analyst Forecast & Price Prediction
Start investing in Welltower (WELL)
Order type
Buy in
Order amount
Est. shares
0 shares